These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31492)

  • 21. The vasoconstriction-volume spectrum in normotension and in the pathogenesis of hypertension.
    Laragh JH; Sealey JE; Niarchos AP; Pickering TG
    Fed Proc; 1982 Jun; 41(8):2415-23. PubMed ID: 7084486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The renin system in essential, renovascular and adrenocortical hypertension: an overview.
    Laragh JH
    Adv Nephrol Necker Hosp; 1977; 7():157-89. PubMed ID: 96672
    [No Abstract]   [Full Text] [Related]  

  • 23. Renovascular hypertension: a paradigm for all hypertension.
    Laragh JH
    J Hypertens Suppl; 1986 Oct; 4(4):S79-88. PubMed ID: 3534186
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of the angiotensin converting enzyme inhibitors captopril, rentiapril, and alacepril in patients with essential and renovascular hypertension.
    Ideishi M; Sasaguri M; Ikeda M; Arakawa K
    Clin Ther; 1989; 11(4):441-51. PubMed ID: 2550133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hypertension therapy in patients with renal artery stenosis].
    Vogt B; Maillard M; Burnier M
    Ther Umsch; 2012 May; 69(5):279-81. PubMed ID: 22547359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypertension: relationships between pathophysiology and therapy.
    Bailie MD; Mattioli LF
    J Pediatr; 1980 May; 96(5):789-97. PubMed ID: 6102595
    [No Abstract]   [Full Text] [Related]  

  • 27. Reversal of renovascular hypertension: a comparison of changes in blood pressure, plasma renin, and sodium balance in two models in rats.
    Godfrey N; Kumar A; Bing RF; Swales JD; Thurston H
    J Lab Clin Med; 1985 Jun; 105(6):679-85. PubMed ID: 3889199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of chronic beta-receptor blockade in blood pressure and renin and aldosterone secretion in essential hypertension].
    Stumpe KO; Vetter H; Hessenbroch V; Kolloch R; Düsing R; Krück F
    Verh Dtsch Ges Inn Med; 1975; 81():1038-41. PubMed ID: 7048
    [No Abstract]   [Full Text] [Related]  

  • 29. Cardiac consequences of aldosterone excess in human hypertension.
    Rossi GP
    Am J Hypertens; 2006 Jan; 19(1):10-2. PubMed ID: 16461183
    [No Abstract]   [Full Text] [Related]  

  • 30. [Physiopathology of arterial hypertension. II--The renin-angiotensin-aldosterone system].
    Francischetti EA; Oigman W; Fagundes VG; Sanjuliani AF; Netto FR; Brandão AP
    Arq Bras Cardiol; 1985 Jan; 44(1):57-71. PubMed ID: 3904677
    [No Abstract]   [Full Text] [Related]  

  • 31. The renin system for understanding human hypertension: evidence for blood pressure control by a bipolar vasoconstriction-volume mechanism. Prorenin as a determinant of renin secretion.
    Laragh JH; Sealey JE; Atlas SA
    Clin Exp Hypertens A; 1982; 4(11-12):2303-37. PubMed ID: 6756698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Some aspects of kidney function, the renin-aldosterone system and sympathetic activity in essential hypertension.
    Pedersen EB
    Acta Med Scand Suppl; 1980; 636():1-66. PubMed ID: 6103641
    [No Abstract]   [Full Text] [Related]  

  • 33. Role of aldosterone in left ventricular hypertrophy in hypertension.
    Matsumura K; Fujii K; Oniki H; Oka M; Iida M
    Am J Hypertens; 2006 Jan; 19(1):13-8. PubMed ID: 16461184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renin-aldosterone system suppression during water immersion in renovascular hypertension.
    Coruzzi P; Biggi A; Musiari L; Ravanetti C; Novarini A
    Clin Sci (Lond); 1985 May; 68(5):609-12. PubMed ID: 3884242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renin and angiotensin.
    Lancet; 1968 Aug; 2(7563):335-6. PubMed ID: 4173742
    [No Abstract]   [Full Text] [Related]  

  • 36. Beta-adrenergic blockade, blood pressure, and the renin-angiotensin system.
    Gross F
    Eur J Clin Invest; 1977 Oct; 7(5):321-2. PubMed ID: 21795
    [No Abstract]   [Full Text] [Related]  

  • 37. [Correlations between blood pressure, blood volume and plasma renin during therapy with diuretics in essential hypertension. Comparison between the mineralocorticoid antagonist spironolactone and the "loop" diuretic mefruside].
    Beretta-Piccoli C; Weidmann P; de Châtel R; Hirsch D; Reubi FC
    Schweiz Med Wochenschr; 1977 Jan; 107(4):104-15. PubMed ID: 834983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute inhibition of the renin-angiotensin system: interest and limits to detect surgically curable hypertension.
    Pagny JY; Thibonnier M; Corvol P; Menard J
    J Cardiovasc Pharmacol; 1985; 7 Suppl 4():S82-5. PubMed ID: 2412019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discordant nephron function. A pathogenic factor in hypertension and its vascular complications of stroke and heart attack.
    Laragh JH
    Am J Hypertens; 1991 Jan; 4(1 Pt 2):2S-6S. PubMed ID: 2009143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aldosterone Contributes to Sympathoexcitation in Renovascular Hypertension.
    Lincevicius GS; Shimoura CG; Nishi EE; Perry JC; Casarini DE; Gomes GN; Bergamaschi CT; Campos RR
    Am J Hypertens; 2015 Sep; 28(9):1083-90. PubMed ID: 25628418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.